Home Business Technology AI Drug Firm METiS Considering $200 Million Hong Kong IPO, Sources Say
Technology

AI Drug Firm METiS Considering $200 Million Hong Kong IPO, Sources Say

Share
AI Drug Firm METiS Considering $200 Million Hong Kong IPO, Sources Say
AI Drug Firm METiS Considering $200 Million Hong Kong IPO, Sources Say
Share

Artificial intelligence-driven drug firm METiS Pharmaceuticals is considering an initial public offering in Hong Kong to raise as much as $200 million, according to people familiar with the matter.
Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Microsoft Is Cutting Thousands of Employees Across the Company
Technology

Microsoft Is Cutting Thousands of Employees Across the Company

Microsoft Corp. said it will cut thousands of workers with a focus...

Intel Certifies Shell Lubricant for Cooling AI Data Centers
Technology

Intel Certifies Shell Lubricant for Cooling AI Data Centers

Intel Corp. has certified Shell Plc’s lubricant-based method for cooling servers more...

UBS’s Lo Says Investors Diversifying From US to Gold, Crypto
Technology

UBS’s Lo Says Investors Diversifying From US to Gold, Crypto

UBS Group AG’s rich clients are increasingly shifting away from US-dollar assets,...

Microsoft Among Software Stocks Offering Haven in Tariff Chaos
Technology

Microsoft Among Software Stocks Offering Haven in Tariff Chaos

As the Trump administration’s trade war clouds the economic outlook, software stocks...